OpenAlex
PricingAboutJobs
Log inGet started
Work

Two Phase 2 Multiple Ascending–Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer’s Disease

HTML

Year: 2016
Type: article
Study design: Clinical Trial
Source: Journal of Alzheimer s Disease
DOI: 10.3233/jad-150376
Authors: Florence Pasquier, Carl Sadowsky, Ann Holstein, Ghislaine Le Prince Leterme, Yahong Peng, Nicholas Jackson, Nick C. Fox, Nzeera Ketter, Enchi Liu, J. Michael Ryan, for the ACC-001 (QS-21) Study Team
Institutions: Inserm, Université de Lille, Palm Beach Neurology, Premiere Research Institute, Pfizer (United States), Pfizer (France), UCL Queen Square Institute of Neurology, University College London
Language: English

Topic: Alzheimer's disease research and treatments
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
SDG: Good health and well-being

Open Access status: closed

Funders: Pfizer, National Institute for Health and Care Research
Award: NIHR Senior Investigator Award
OpenAlex ID: W2289661106
FWCI: 3.652
Cites: 32
Cited by: 117
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security